Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma

Roswell Park Cancer Institute, Buffalo

Christiana Care Health System-Christiana Hospital, Newark

MedStar Georgetown University Hospital, Washington D.C.

MedStar Washington Hospital Center, Washington D.C.

Danville Regional Medical Center, Danville

Wake Forest University Health Sciences, Winston-Salem

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

Novant Health Presbyterian Medical Center, Charlotte

Lenoir Memorial Hospital, Kinston

Greenville Health System Cancer Institute-Eastside, Greenville

AdventHealth Orlando, Orlando

Mount Sinai Medical Center, Miami Beach

Holy Cross Hospital, Fort Lauderdale

Jupiter Medical Center, Jupiter

Minneapolis VA Medical Center, Minneapolis

University of Chicago Comprehensive Cancer Center, Chicago

Washington University School of Medicine, St Louis

Missouri Baptist Medical Center, St Louis

Center for Cancer Care and Research, St Louis

Kansas City NCI Community Oncology Research Program, Prairie Village

Palo Alto Medical Foundation-Camino Division, Mountain View

Walter Reed National Military Medical Center, Bethesda

Frisbie Hospital, Rochester

Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners

University of Vermont and State Agricultural College, Burlington